The Hyperion Fund functions as a syndicated venture capital fund that provides independent investors access to the earliest stages of investing in blockchain projects. Through the IHF token, investors gain diversified exposure to a portfolio of expertly-vetted investments in private and public pre-sales, and ICOs. Invictus analysts leverage proprietary analysis tools (such as the Titan AI tool) to navigate the higher risk characteristic of these early-stage investments.
The gene source chain system will create the world's first distributed storage network public chain system that provides genetic data and individual health data. Health and medical providers, including chronic disease management agencies and health counseling providers, can use the Gene Source Chain System to create DApps. These applications will provide users with personalized and accurate health services based on genome and health data, subject to user consent. As a proof of concept, the Gene Source Chain Foundation will also support the creation of a gamified health DApp to help build the ecosystem.